Ludwig-Maximilians-Universität (LMU)

eImmunonkologie: Development and Launch of a Virtual Education Platform for the Immunotherapy of Cutaneous Neoplasms (2022) Kaufmann M, Steeb T, Wessely A, Meyerolbersleben M, French LEE, Berking C, Heppt M Journal article A FHIR has been lit on gICS: facilitating the standardised exchange of informed consent in a large network of university medicine (2022) Bialke M, Geidel L, Hampf C, Blumentritt A, Penndorf P, Schuldt R, Moser FM, et al. Journal article Enhanced Spike-specific, but attenuated Nucleocapsid-specific T cell responses upon SARS-CoV-2 breakthrough versus non-breakthrough infections (2022) Ahmed MIM, Diepers P, Janke C, Plank M, Eser TM, Rubio-Acero R, Fuchs A, et al. Journal article Real-world outcomes using PD-1 antibodies and BRAF plus MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland (2022) Schumann K, Mauch C, Klespe KC, Loquai C, Nikfarjam U, Schlaak M, Akcetin L, et al. Journal article Prognostic markers for the clinical course in the blood of patients with SARS-CoV-2 infection (2022) Fischer JC, Balz V, Jazmati D, Bölke E, Freise NF, Keitel V, Feldt T, et al. Journal article 18F-FET PET radiomics-based survival prediction in glioblastoma patients receiving radio(chemo)therapy (2022) Wiltgen T, Fleischmann DF, Kaiser L, Holzgreve A, Corradini S, Landry G, Ingrisch M, et al. Journal article MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clinical trial (MASPAC) (2022) Pavic M, Niyazi M, Wilke L, Corradini S, Vornhülz M, Mansmann U, Al Tawil A, et al. Journal article Shared Data and Algorithms for Deep Learning in Fundamental Physics (2022) Benato L, Buhmann E, Erdmann M, Fackeldey P, Glombitza J, Hartmann N, Kasieczka G, et al. Journal article, Original article Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy—the MecMeth/NOA-24 trial (2022) Zeyen T, Potthoff AL, Nemeth R, Heiland DH, Burger MC, Steinbach JP, Hau P, et al. Journal article Field emission microscope for a single fullerene molecule (2022) Yanagisawa H, Bohn M, Goschin F, Seitsonen AP, Kling MF Journal article